SenzaGen Cash And Equivalents vs. Total Debt
| SENZA Stock | SEK 7.15 0.20 2.88% |
For SenzaGen profitability analysis, we use financial ratios and fundamental drivers that measure the ability of SenzaGen to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well SenzaGen AB utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between SenzaGen's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of SenzaGen AB over time as well as its relative position and ranking within its peers.
SenzaGen |
SenzaGen AB Total Debt vs. Cash And Equivalents Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining SenzaGen's current stock value. Our valuation model uses many indicators to compare SenzaGen value to that of its competitors to determine the firm's financial worth. SenzaGen AB is currently regarded as top stock in cash and equivalents category among its peers. It also is currently regarded number one company in total debt category among its peers making up about 0.01 of Total Debt per Cash And Equivalents. The ratio of Cash And Equivalents to Total Debt for SenzaGen AB is roughly 96.87 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the SenzaGen's earnings, one of the primary drivers of an investment's value.SenzaGen Total Debt vs. Cash And Equivalents
Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
SenzaGen |
| = | 69.16 M |
Cash equivalents represent current assets that are easily convertible to cash such as short term bonds, savings account, money market funds, or certificate of deposits (CDs). One of the important consideration companies make when classifying assets as cash equivalent is that investments they report on their balance sheets under current assets should have almost no risk of change in value over the next few months (usually three months).
Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
SenzaGen |
| = | 714 K |
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
SenzaGen Total Debt vs Competition
SenzaGen AB is currently regarded number one company in total debt category among its peers. Total debt of Biotechnology industry is at this time estimated at about 36.12 Million. SenzaGen claims roughly 714,000 in total debt contributing just under 2% to stocks in Biotechnology industry.
SenzaGen Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in SenzaGen, profitability is also one of the essential criteria for including it into their portfolios because, without profit, SenzaGen will eventually generate negative long term returns. The profitability progress is the general direction of SenzaGen's change in net profit over the period of time. It can combine multiple indicators of SenzaGen, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
SenzaGen AB, together with its subsidiary, markets, sells, and performs in vitro genomic allergen rapid detection sensitization tests for the screening of pharmaceutical candidates, and safety assessment of chemicals and cosmetic ingredients in Sweden and internationally. SenzaGen AB was incorporated in 2010 and is headquartered in Lund, Sweden. SenzaGen is traded on Stockholm Stock Exchange in Sweden.
SenzaGen Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on SenzaGen. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of SenzaGen position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the SenzaGen's important profitability drivers and their relationship over time.
Use SenzaGen in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if SenzaGen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in SenzaGen will appreciate offsetting losses from the drop in the long position's value.SenzaGen Pair Trading
SenzaGen AB Pair Trading Analysis
The ability to find closely correlated positions to SenzaGen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace SenzaGen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back SenzaGen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling SenzaGen AB to buy it.
The correlation of SenzaGen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as SenzaGen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if SenzaGen AB moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for SenzaGen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your SenzaGen position
In addition to having SenzaGen in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Petroleum and Natural Gas Thematic Idea Now
Petroleum and Natural Gas
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Petroleum and Natural Gas theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Petroleum and Natural Gas Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for SenzaGen Stock Analysis
When running SenzaGen's price analysis, check to measure SenzaGen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SenzaGen is operating at the current time. Most of SenzaGen's value examination focuses on studying past and present price action to predict the probability of SenzaGen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SenzaGen's price. Additionally, you may evaluate how the addition of SenzaGen to your portfolios can decrease your overall portfolio volatility.